-
December 21, 2022 Lupin Diagnostics Expands its Footprint in Central India; Launches Regional Reference Laboratory in Indore
-
December 21, 2022 Lupin Receives Approval from U.S. FDA for Brivaracetam Tablets
-
December 9, 2022 Lupin Launches Authorized Generic Version of PENNSAID® 2% w/w in the United States
-
December 8, 2022 Lupin Appoints Spiro Gavaris as President of U.S. Generics Business
-
December 5, 2022 Lupin Launches Rufinamide Tablets USP in the United States
-
November 29, 2022 Lupin Launches Formoterol Fumarate Inhalation Solution in the United States
-
November 28, 2022 Lupin’s Brazilian Subsidiary, MedQuimica Acquires Rights to Nine Brands from Bausch Health
-
November 21, 2022 Lupin Signs MoU with the Government of Rajasthan to strengthen Healthcare system
-
November 14, 2022 Luforbec® 200/6 (beclometasone 200mcg / formoterol 6mcg) a certified carbon neutral inhaler is launched in the UK for the treatment of adult asthma1,2,3
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications